| Training set | Validation set |  |
---|---|---|---|
 | Overall (N = 8) | Overall (N = 84) |  |
Sex | Â | Â | Â |
F | 2 (25.0%) | 17 (20.2%) | Â |
M | 6 (75.0%) | 67 (79.8%) | Â |
Age | Â | Â | Â |
Mean (SD) | 73.5 (8.8) | 70.6 (8.6) | Â |
Side | Â | Â | Â |
Left | 2 (25.0%) | 29 (35.8%) | Â |
Right | 6 (75.0%) | 52 (64.2%) | Â |
N-Miss | Â | 3 | Â |
Surgery | Â | Â | Â |
Biopsy | 5 (62.5%) | 49 (59.0%) | Â |
Pleurectomy | 3 (37.5%) | 34 (41.0%) | Â |
N-Miss | Â | 1 | Â |
Histology | Â | Â | Â |
Epithelioid | 0 (0%) | 34 (40.5%) | Â |
Biphasic | 8 (100.0%) | 32 (38.1%) | Â |
Sarcomatoid | 0 (0%) | 18 (21.4%) | Â |
Stage | Â | Â | Â |
I | 4 (50%) | 38 (47.6%) | Â |
II | 0 (0%) | 4 (5.0%) | Â |
III | 0 (0%) | 7 (8.7%) | Â |
IV | 4 (50%) | 31 (38.8%) | Â |
N-Miss | Â | 4 | Â |
Death | Â | Â | Â |
No | 2 (25%) | 8 (9.6%) | Â |
Yes | 6 (75%) | 75 (90.4%) | Â |
N-Miss | Â | 1 | Â |
Overall survival (months) | Â | Â | Â |
Mean (SD) | 11.9 (8.1) | 20.3 (20.6) | Â |
N-Miss | Â | 3 | Â |